Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Glaukos Corporation
Age
45–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
clinically significant age-related cataract eligible for phacoemulsification in the study eye
open-angle glaucoma or ocular hypertension in the study eye
successful, uncomplicated cataract surgery using small incision phacoemulsification cataract surgery and insertion of a foldable posterior chamber IOL
You may not be if
unmedicated (washed out) IOP of \>36 mmHg in the study eye
hypersensitivity to travoprost or any other components of the travoprost intraocular implant
vertical cup/disc ratio \> 0.8 in the study eye
best spectacle corrected visual acuity of worse than 20/80 in the fellow eye
any ocular disease or condition that, in the opinion of the investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study
Clareo Health | Travoprost Intraocular Implant in Conjunction With Cataract Surgery
